Allergan’s TrueTear granted marketing authorization

The TrueTear intranasal tear neurostimulator has been granted marketing authorization from the FDA, according to an Allergan press release.The hand-held stimulator is the first FDA-cleared device for temporarily increasing tear production during neurostimulation. The device has disposable tips and is inserted into the nasal cavity to induce the production of tears, the release said.